Related Experiment Video

Updated: May 27, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Clobetasol synergistically diminishes Ciz1 expression with genistein in U937 cells

Naoko Okumura1, Hitomi Yoshida, Yuri Nishimura

  • 1Department of Environmental Health Science, Nara Women's University, Nara 630-8506, Japan.

Molecular Medicine Reports
|November 15, 2011
PubMed

Insights

Medicinal glucocorticoids, like clobetasol, can reduce Cip-interacting zinc finger protein 1 (Ciz1) expression, a protein linked to breast cancer. This suggests potential therapeutic applications for glucocorticoids in treating breast cancer.

Area of Science:

  • Molecular biology
  • Oncology
  • Pharmacology

Background:

  • Cip-interacting zinc finger protein 1 (Ciz1) promotes DNA replication and is implicated in breast cancer tumorigenesis.
  • Investigating novel therapeutic strategies for breast cancer is crucial.

Purpose of the Study:

  • To determine if medicinal glucocorticoids impact Ciz1 expression.
  • To explore clobetasol's effect on Ciz1 in breast cancer cells.

Main Methods:

  • In vitro study using reverse transcriptase-polymerase chain reaction (RT-PCR) to detect Ciz1 expression.
  • Western blotting to confirm protein down-regulation.
  • Treatment with clobetasol, genistein, and Lens culinaris extract.

Main Results:

  • Clobetasol treatment reduced Ciz1 expression in a dose-dependent manner.
  • Ciz1 protein levels decreased following pre-treatment with clobetasol and genistein.
  • Lens culinaris extract showed a synergistic effect in repressing Ciz1 protein expression.

Conclusions:

  • Medicinal glucocorticoids, exemplified by clobetasol, can down-regulate Ciz1 expression.
  • These findings suggest a potential role for glucocorticoids in breast cancer therapy by targeting Ciz1.
Keywords:
Cip-interacting zinc finger protein 1glucocorticoidAG490genisteingene expressioncancer

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...